aXichem
2.36 SEK
-0.42 %
Less than 1K followers
AXIC A
First North Stockholm
Chemicals
Basic Materials
Overview
Financials & Estimates
Ownership
Investor consensus
-0.42 %
-8.17 %
-23.87 %
-18.06 %
+74.17 %
+86.56 %
-81.42 %
-95.07 %
-86.02 %
aXichem is active in industrial biotechnology. The company develops, patents and markets industrial chemicals. The company works mainly with Phenylcapsaicin, a natural analogue synthetic capsaicin with applications in a variety of areas, such as in the marine sector, among pest control in forestry and agriculture, and among individual pharmaceutical work areas. Operations are conducted on a global level, with headquarters in Malmö.
Read moreMarket cap
139.51M SEK
Turnover
51.89K SEK
Revenue
8.57M
EBIT %
-184.71 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
26.2
2026
Annual report '25
21.5
2026
Interim report Q1'26
17.6
2026
General meeting '26
All
Press releases
ShowingAll content types
aXichem AB: aXichem secures production capacity for phenylcapsaicin, corresponding to volumes of up to 100 tons of aXiphen-feed, for the upcoming six to nine months
aXichem AB: aXichem exhibits at Vitafoods Europe 2021 in Geneva, and launches a new website presenting the unique product aXivite
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools